Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Activity and subcellular distribution of cathepsins in primary human monocytes
Greiner A, Lautwein A, Overkleeft H, Weber E, Driessen C. Activity and subcellular distribution of cathepsins in primary human monocytes. Journal of leukocyte biology 2003; 73:235-42.
Feb 1, 2003Activity and subcellular distribution of cathepsins in primary human monocytes
Feb 1, 2003Journal of leukocyte biology 2003; 73:235-42
Greiner Andrea, Lautwein Alfred, Overkleeft Herman S, Weber Ekkehard, Driessen Christoph
A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis
Aapro M, Thürlimann B, Sessa C, De Pree C, Bernhard J, Maibach R, Swiss Group for Clinical Cancer Research. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003; 14:291-7.
Feb 1, 2003A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis
Feb 1, 2003Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003; 14:291-7
Aapro M S, Thürlimann Beat, Sessa C, De Pree C, Bernhard J, Maibach R, Swiss Group for Clinical Cancer Research
Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
Seeger H, Diesing D, Gückel B, Wallwiener D, Mueck A, Huober J. Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation. The Journal of steroid biochemistry and molecular biology 2003; 84:255-7.
Feb 1, 2003Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
Feb 1, 2003The Journal of steroid biochemistry and molecular biology 2003; 84:255-7
Seeger H, Diesing D, Gückel B, Wallwiener D, Mueck A O, Huober Jens
Trends in clinical trials in surgical oncology: implications for outcomes research
Gueller U, Blumenstein B. Trends in clinical trials in surgical oncology: implications for outcomes research. Clin Ther 2003; 25:684-98.
Feb 1, 2003Trends in clinical trials in surgical oncology: implications for outcomes research
Feb 1, 2003Clin Ther 2003; 25:684-98
Gueller Ulrich, Blumenstein Brent A
[Intravitreal chemotherapy for intraocular lymphoma]
Helbig H, Cerny T, de Smet M. [Intravitreal chemotherapy for intraocular lymphoma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2003; 100:145-9.
Feb 1, 2003[Intravitreal chemotherapy for intraocular lymphoma]
Feb 1, 2003Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2003; 100:145-9
Helbig H, Cerny Thomas, de Smet M D
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Rehwald U, Engert A, Diehl V, Muller-Hermelink K, Rüdiger T, Driessen C, Morschhauser F, Staak J, Sieber M, Reiser M, Schulz H, German Hodgkin Lymphoma Study Group (GHSG). Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003; 101:420-4.
Jan 15, 2003Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
Jan 15, 2003Blood 2003; 101:420-4
Rehwald Ute, Engert Andreas, Diehl Volker, Muller-Hermelink Konrad, Rüdiger Thomas, Driessen Christoph, Morschhauser Franck, Staak Jan Oliver, Sieber Markus, Reiser Marcel, Schulz Holger, German Hodgkin Lymphoma Study Group (GHSG)
Malignant liver tumors: Current and emerging therapies
Pestalozzi B, Jörger M. Malignant liver tumors: Current and emerging therapies - Systematic treatment of hepatobiliary tumors. In: Malignant liver tumors: Current and emerging therapies. 2nd editionJones and Bartlett Publishers, 2003. ISBN 9780763718572. pp. 91-99.
Jan 1, 2003Malignant liver tumors: Current and emerging therapies
Jan 1, 2003Jones and Bartlett Publishers, ISBN 9780763718572
Pestalozzi BC, Jörger Markus
Side Effects of Drugs Annual 26
Kuhn M, Jörger M, Hartmann K. Side Effects of Drugs Annual 26 - Drugs acting on the respiratory tract. In: Side Effects of Drugs Annual 26. Oxford UK: Elsevier; Linacre House Jordan Hill, 2003. ISBN 0-444-50999-2.
Jan 1, 2003Side Effects of Drugs Annual 26
Jan 1, 2003Elsevier; Linacre House Jordan Hill, ISBN 0-444-50999-2
Kuhn M, Jörger Markus, Hartmann K
Wieviel Psycho braucht die Seelsorge?
Renz M. Wieviel Psycho braucht die Seelsorge? - Psychotherapie und/oder Seelsorge in der Arbeit mit Schwerkranken und Sterbenden. Diakonia 2003; 34:259-266.
Jan 1, 2003Wieviel Psycho braucht die Seelsorge?
Jan 1, 2003Diakonia 2003; 34:259-266
Renz Monika
Temozolomid in der Behandlung maligner Gliome
Hundsberger T, Koch D, Klimpe S, Schlegel U. Temozolomid in der Behandlung maligner Gliome. Aktuelle Neurologie 2003; 30:184-187.
Jan 1, 2003Temozolomid in der Behandlung maligner Gliome
Jan 1, 2003Aktuelle Neurologie 2003; 30:184-187
Hundsberger Thomas, Koch Dorothee, Klimpe Sven, Schlegel Uwe
Verlaufsveränderungen des Burst-Suppression-EEG bei hypoxischer Hirnschädigung nach kardiopulmonaler Reanimation
Thömke F, Weilemann S, Hundsberger T, Marx J, Sauer O, Hägele-Link S, Dieterich M. Verlaufsveränderungen des Burst-Suppression-EEG bei hypoxischer Hirnschädigung nach kardiopulmonaler Reanimation. Klinische Neurophysiologie 2003; 34:86-93.
Jan 1, 2003Verlaufsveränderungen des Burst-Suppression-EEG bei hypoxischer Hirnschädigung nach kardiopulmonaler Reanimation
Jan 1, 2003Klinische Neurophysiologie 2003; 34:86-93
Thömke Frank, Weilemann Sacha L, Hundsberger Thomas, Marx Jürgen, Sauer Oliver, Hägele-Link Stefan, Dieterich M
Chemotheraphie des Endometriumkarzinoms
Huober J, Gruber I, Fehm T. Chemotheraphie des Endometriumkarzinoms. Onkologe 2003; 9:1241-1244.
Jan 1, 2003Chemotheraphie des Endometriumkarzinoms
Jan 1, 2003Onkologe 2003; 9:1241-1244
Huober Jens, Gruber I, Fehm T
St. Gallen 2003 - Was tun?
Wallwiener D, Huober J. St. Gallen 2003 - Was tun?. Frauenarzt 2003; 44:516-517.
Jan 1, 2003St. Gallen 2003 - Was tun?
Jan 1, 2003Frauenarzt 2003; 44:516-517
Wallwiener D, Huober Jens
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study
D'Addario G, Ketterer N, Fey M, Cavalli F, Lohri A, Egli F, Stahel R, Maibach R, Torhorst J, Dieterle A, Cerny T. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study. Leukemia & lymphoma 2003; 44:133-8.
Jan 1, 2003HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study
Jan 1, 2003Leukemia & lymphoma 2003; 44:133-8
D'Addario Giannicola, Ketterer Nicolas, Fey Martin, Cavalli Franco, Lohri Andreas, Egli Fritz, Stahel Rolf, Maibach Rudolf, Torhorst Joachim, Dieterle Alexander, Cerny Thomas
Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells
Lautwein A, Burster T, Lennon-Duménil A, Overkleeft H, Weber E, Kalbacher H, Driessen C. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. European journal of immunology 2002; 32:3348-57.
Dec 1, 2002Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells
Dec 1, 2002European journal of immunology 2002; 32:3348-57
Lautwein Alfred, Burster Timo, Lennon-Duménil Ana-Maria, Overkleeft Herman S, Weber Ekkehard, Kalbacher Hubert, Driessen Christoph
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
Jörger M, Öhlschlegel C, Cerny T, Gillessen Sommer S. Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin. Onkologie 2002; 25:558-61.
Dec 1, 2002Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
Dec 1, 2002Onkologie 2002; 25:558-61
Jörger Markus, Öhlschlegel Christian, Cerny Thomas, Gillessen Sommer Silke
The proteasome, a new target for cancer therapy
Gillessen Sommer S, Groettup M, Cerny T. The proteasome, a new target for cancer therapy. Onkologie 2002; 25:534-9.
Dec 1, 2002The proteasome, a new target for cancer therapy
Dec 1, 2002Onkologie 2002; 25:534-9
Gillessen Sommer Silke, Groettup M, Cerny Thomas
[CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]
Gückel B, Stumm S, Kayser S, Rentzsch C, Gruber I, Marmé A, Huober J, Meuer S, Wallwiener D. [CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]. Zentralblatt für Gynäkologie 2002; 124:566-73.
Dec 1, 2002[CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]
Dec 1, 2002Zentralblatt für Gynäkologie 2002; 124:566-73
Gückel B, Stumm S, Kayser S, Rentzsch C, Gruber I, Marmé A, Huober Jens, Meuer S C, Wallwiener D
Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer
Gueller U, Heberer M, Harder F, Metzger U, Maurer R, Oertli D, Spagnoli G, Zuber M, Vorburger S, Bösch B, Schnider A, Zajac P, Marti W. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002; 236:768-75; discussion 775-6.
Dec 1, 2002Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer
Dec 1, 2002Ann Surg 2002; 236:768-75; discussion 775-6
Gueller Ulrich, Heberer Michael, Harder Felix, Metzger Urs, Maurer Robert, Oertli Daniel, Spagnoli Giulio Cesare, Zuber Markus, Vorburger Stefan, Bösch Beatrix, Schnider Annelies, Zajac Paul, Marti Walter Richard
Characterization of legumain
Schwarz G, Brandenburg J, Reich M, Burster T, Driessen C, Kalbacher H. Characterization of legumain. Biological chemistry 2002; 383:1813-6.
Nov 1, 2002Characterization of legumain
Nov 1, 2002Biological chemistry 2002; 383:1813-6
Schwarz Gerold, Brandenburg Jens, Reich Michael, Burster Timo, Driessen Christoph, Kalbacher Hubert